1 Poliomyelitis Vaccine Market Overview
1.1 Poliomyelitis Vaccine Product Scope
1.2 Poliomyelitis Vaccine Segment by Type
1.2.1 Global Poliomyelitis Vaccine Sales by Type (2020-2026)
1.2.2 Poliomyelitis Vaccine Ⅰ
1.2.3 Poliomyelitis Vaccine Ⅱ
1.2.4 Poliomyelitis Vaccine Ⅲ
1.2.5 Oral Poliomyelitis Vaccine
1.3 Poliomyelitis Vaccine Segment by Application
1.3.1 Global Poliomyelitis Vaccine Sales Comparison by Application (2020-2026)
1.3.2 VAPP
1.3.3 VDPV
1.4 Poliomyelitis Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Poliomyelitis Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Poliomyelitis Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Poliomyelitis Vaccine Price Trends (2015-2026)
2 Poliomyelitis Vaccine Estimate and Forecast by Region
2.1 Global Poliomyelitis Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Poliomyelitis Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Poliomyelitis Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Poliomyelitis Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Poliomyelitis Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Poliomyelitis Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Poliomyelitis Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Poliomyelitis Vaccine Estimates and Projections (2015-2026)
2.4.3 China Poliomyelitis Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Poliomyelitis Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Poliomyelitis Vaccine Estimates and Projections (2015-2026)
2.4.6 India Poliomyelitis Vaccine Estimates and Projections (2015-2026)
3 Global Poliomyelitis Vaccine Competition Landscape by Players
3.1 Global Top Poliomyelitis Vaccine Players by Sales (2015-2020)
3.2 Global Top Poliomyelitis Vaccine Players by Revenue (2015-2020)
3.3 Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Vaccine as of 2019)
3.4 Global Poliomyelitis Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Poliomyelitis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Poliomyelitis Vaccine Players (Opinion Leaders)
4 Global Poliomyelitis Vaccine Market Size by Type
4.1 Global Poliomyelitis Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Poliomyelitis Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Poliomyelitis Vaccine Price by Type (2015-2020)
4.2 Global Poliomyelitis Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Poliomyelitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Poliomyelitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Poliomyelitis Vaccine Price Forecast by Type (2021-2026)
5 Global Poliomyelitis Vaccine Market Size by Application
5.1 Global Poliomyelitis Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Poliomyelitis Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Poliomyelitis Vaccine Price by Application (2015-2020)
5.2 Global Poliomyelitis Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Poliomyelitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Poliomyelitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Poliomyelitis Vaccine Price Forecast by Application (2021-2026)
6 United States Poliomyelitis Vaccine Market Facts & Figures
6.1 United States Poliomyelitis Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
7 Europe Poliomyelitis Vaccine Market Facts & Figures
7.1 Europe Poliomyelitis Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
8 China Poliomyelitis Vaccine Market Facts & Figures
8.1 China Poliomyelitis Vaccine Sales Market Share by Company (2015-2020)
8.2 China Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
8.3 China Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
9 Japan Poliomyelitis Vaccine Market Facts & Figures
9.1 Japan Poliomyelitis Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Poliomyelitis Vaccine Market Facts & Figures
10.1 Southeast Asia Poliomyelitis Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
11 India Poliomyelitis Vaccine Market Facts & Figures
11.1 India Poliomyelitis Vaccine Sales Market Share by Company (2015-2020)
11.2 India Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
11.3 India Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Poliomyelitis Vaccine Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Poliomyelitis Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Business Overview
12.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Poliomyelitis Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 Crucell
12.4.1 Crucell Corporation Information
12.4.2 Crucell Business Overview
12.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Crucell Poliomyelitis Vaccine Products Offered
12.4.5 Crucell Recent Development
12.5 China National Biotech Group
12.5.1 China National Biotech Group Corporation Information
12.5.2 China National Biotech Group Business Overview
12.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 China National Biotech Group Poliomyelitis Vaccine Products Offered
12.5.5 China National Biotech Group Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Business Overview
12.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly Poliomyelitis Vaccine Products Offered
12.6.5 Eli Lilly Recent Development
…
13 Poliomyelitis Vaccine Manufacturing Cost Analysis
13.1 Poliomyelitis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Poliomyelitis Vaccine
13.4 Poliomyelitis Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Poliomyelitis Vaccine Distributors List
14.3 Poliomyelitis Vaccine Customers
15 Market Dynamics
15.1 Poliomyelitis Vaccine Market Trends
15.2 Poliomyelitis Vaccine Opportunities and Drivers
15.3 Poliomyelitis Vaccine Market Challenges
15.4 Poliomyelitis Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
【掲載企業】
GSK、Sanofi-Pasteur、Merck、Crucell、China National Biotech Group、Eli Lilly
【免責事項】
https://www.globalresearch.jp/disclaimer